Back to the articles
Having IMPACTT 2023: The Rosell® Institute for Microbiome and Probiotics Renews Its Platinum Sponsorship
The Rosell® Institute for Microbiome and Probiotics by Lallemand reconducts its platinum sponsorship of the Canadian microbiome symposium, Having IMPACTT, for a third year in a row.
Having IMPACTT 3: Advancing Microbiome Research will take place from July 10 to 12, at the Malcolm Hotel in Canmore, Canada. Scientists from across Canada and around the world will gather to highlight what’s new in microbiome research. The organizers, the Integrated Microbiome Platforms for Advancing Causation Testing and Translation (IMPACTT) and the International Microbiome Centre (IMC), both based at the University of Calgary, have built a program that will be of interest to researchers, clinicians, and trainees.
Reuniting over 15 renowned speakers, the themes that will be covered in this symposium include: Microbiome Beyond Bacteria; Microbiome Beyond the Gut; Microbiome Across Life Stages; Microbiome & Nutrition; Omics & Bioinformatics.
“The importance of human microbiome research is rapidly gaining momentum for understanding its role in human health and disease. Our goal for this symposium is to bring together the leading minds in microbiome research and highlight the emerging microbiome teams from across Canada,” explains Kathy McCoy, PhD, IMPACTT Director and Professor in the Dept. of Physiology and Pharmacology, as well Scientific Director of the IMC at the University of Calgary.
“This event is totally aligned with our own commitment towards microbiome research and development, the promotion of innovative science and the exchange of ideas. We are happy to have the opportunity to sponsor this event and encourage a great Canadian initiative in this area,” adds Stéphane Bronner, Research Director at the Rosell® Institute.
This third edition is sold out, sign of the success of previous editions.
IMPACTT is the cross-disciplinary Canadian Microbiome Research core funded by the Canadian Institutes of Health Research to move Canada’s microbiome research from causation testing to translational studies and reinforce Canada’s position as an international leader in microbiome research. The IMPACTT core offers technological and analytical expertise to microbiome researchers by giving them access to multi-disciplinary world-class facilities across Canada. The IMPACTT consortium supports microbiome researchers to harness the power of our microbes, and help identify novel therapeutics and approaches that will improve human health.
About the Rosell® Institute for Microbiome and Probiotics by Lallemand
The Rosell® Institute for Microbiome and Probiotics’ mission is to apply leading-edge technologies and innovative scientific approaches to the improvement of human health through understanding the interaction between people and their functional microbiome. Through intensive investigation and collaborative studies, our research is focused on understanding the potential of the human microbiome and to remap its functionality using probiotic supplements to improve or maintain health in specific populations or health segments. With over 85 years of know-how, we have 40+ proprietary bacteria strains and over 600+ formulations in our growing portfolio for all major health segments. Worldwide our products are used in over 60 countries and reach millions of patients. Lallemand Health Solutions probiotic strains have been documented in over 350 publications including 160 clinical studies.
Communication Manager, Lallemand Health Solutions
Sydney C. Morgan, Ph.D.
IMPACTT Education & Communication Coordinator
University of Calgary | Cumming School of Medicine